Variant report
Variant | esv3395386 |
---|---|
Chromosome Location | chr2:77916044-77919042 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10170086 | chr2:77918007-77918008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs547642025 | chr2:77918033-77918034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375167218 | chr2:77918102-77918103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72928045 | chr2:77918104-77918105 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187931220 | chr2:77918136-77918137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576387936 | chr2:77918150-77918151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538701298 | chr2:77918171-77918172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs558900401 | chr2:77918182-77918183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572481198 | chr2:77918249-77918250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs541100018 | chr2:77918264-77918265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190892995 | chr2:77918314-77918315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs76724132 | chr2:77918318-77918319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140794554 | chr2:77918328-77918329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563873216 | chr2:77918338-77918339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10185229 | chr2:77918355-77918356 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs74858438 | chr2:77918393-77918394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564876933 | chr2:77918404-77918405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149756072 | chr2:77918433-77918434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371266606 | chr2:77918541-77918542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542157062 | chr2:77918550-77918551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567478177 | chr2:77918589-77918590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562051362 | chr2:77918598-77918599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115208480 | chr2:77918644-77918645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182071576 | chr2:77918690-77918691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs186705189 | chr2:77918712-77918713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371731260 | chr2:77918747-77918748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569890441 | chr2:77918760-77918761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192606729 | chr2:77918762-77918763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558706987 | chr2:77918774-77918775 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566031765 | chr2:77918809-77918810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116742977 | chr2:77918813-77918814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554599084 | chr2:77918880-77918881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs367748667 | chr2:77918931-77918932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531059907 | chr2:77918945-77918946 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543650146 | chr2:77918954-77918955 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557515810 | chr2:77918956-77918957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs551929995 | chr2:77918980-77918981 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4853333 | chr2:77919015-77919016 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs72813201 | chr2:77919036-77919037 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Epilepsy | 22083797 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77918000-77919000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr2:77918200-77918800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr2:77918800-77919200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr2:77919000-77919400 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |